| 1 |
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2100-2132.
|
| 2 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
| 3 |
Yin P, Wang H, Vos T, et al. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013[J]. Chest, 2016, 150(6): 1269-1280.
|
| 4 |
Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease[J]. N Engl J Med, 2004, 350(10): 1005-1012.
|
| 5 |
Milo AP, Judith GA, Martin F, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index[J]. Lancet, 2009, 374(9691): 704-711.
|
| 6 |
Boeck L, Soriano JB, Brusse-Keizer M, et al. Prognostic assessment in COPD without lung function: the B-AE-D indices [J]. Eur Respir J, 2016, 47(6): 1635-1644.
|
| 7 |
2024 G. global initiative for chronic obstructive lung disease [Z].
URL
|
| 8 |
Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 187(7): 728-735.
|
| 9 |
Singhvi D, Bon J. CT imaging and comorbidities in COPD: Beyond lung cancer screening[J]. Chest, 2021, 159(1): 147-153.
|
| 10 |
Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD[J]. N Engl J Med, 2012, 367(10): 913-921.
|
| 11 |
Hill AT, Sullivan AL, Chalmers JD, et al. British thoracic society guideline for bronchiectasis in adults[J]. BMJ Open Respir Res, 2018, 5(1): e000348.
|
| 12 |
Reiff DBWA, Carr DH, Cole PJ, et al. CT findings in bronchiectasis:limited value in distinguishing between idiopathic and specific types[J]. AJR, 1995, 165(2): 261-267.
|
| 13 |
Kirsch J, Buitrago I, Mohammed TLH, et al. Detection of coronary calcium during standard chest computed tomography correlates with multi-detector computed tomography coronary artery calcium score[J]. Int J Cardiovasc Imaging, 2012, 28(5): 1249-1256.
|
| 14 |
Tao J, Shi H, Shen B, et al. The chest CT perspective on sarcopenia:Exploring reference values for muscle mass quantity/quality and its application in old adults[J]. Nutrition, 2024, 128: 112558.
|
| 15 |
Martínez-García MA, David de la Rosa Carrillo, Soler-Cataluña, JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 187(8): 823-831.
|
| 16 |
Romme EAPM, Murchison JT, Phang KF, et al. Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD[J]. J Bone Miner Res, 2012, 27(11): 2338-2343.
|
| 17 |
Moll M, Qiao D, Regan EA, et al. Machine learning and prediction of all-cause mortality in COPD[J]. Chest, 2020, 158(3): 952-964.
|
| 18 |
Chen H, Shu T, Wang L, et al. Pulmonary artery enlargement predicts poor survival in patients with COPD: A meta-analysis[J]. Pulm Circ, 2022, 12(3): e12099.
|
| 19 |
Crisafulli E, Guerrero M, Ielpo A, et al. Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis [J]. Sci Rep, 2018, 8(1): 9236.
|
| 20 |
Polverino E, De Soyza A, Dimakou K, et al. The association between bronchiectasis and chronic obstructive pulmonary disease: data from the european bronchiectasis registry (EMBARC)[J]. Am J Respir Crit Care Med, 2024, 210(1): 119-127.
|
| 21 |
Ezponda A, Casanova C, Divo M, et al. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort[J]. Respirology,2022,27(4):286-293.
|
| 22 |
Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality [J]. Thorax, 2014, 69(8): 718-723.
|
| 23 |
Ezponda A, Casanova C, Cabrera C, et al. Psoas muscle density evaluated by chest CT and long-term mortality in COPD patients [J]. Arch Bronconeumol, 2021, 57(8): 533-539.
|
| 24 |
Kim YW, Lee CH, Hwang HG, et al. Resting hyperinflation and emphysema on the clinical course of COPD[J]. Sci Rep, 2019, 9(1): 3764.
|
| 25 |
Pascual-Guardia S, Badenes-Bonet D, Martin-Ontiyuelo C, et al. Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 1837-1845.
|
| 26 |
Wilson AC, Bon JM, Mason S, et al. Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD [J]. Respir Res, 2022, 23(1): 311.
|
| 27 |
Lange TJ, Bornia C, Stiefel J, et al. Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertension [J]. Pulm Circ, 2013, 3(2): 363-368.
|
| 28 |
Kim SH, Yang B, Yoo JY, et al. Clinical characteristics, radiological features, and disease severity of bronchiectasis according to the spirometric pattern[J]. Sci Rep, 2022, 12(1): 13167.
|
| 29 |
Truong QA, Massaro JM, Rogers IS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study[J]. Circ Cardiovasc Imaging, 2012, 5(1): 147-154.
|
| 30 |
Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial[J]. Am J Respir Crit Care Med, 2018, 198(1): 51-57.
|
| 31 |
Pishgar F, Shabani M, Quinaglia AC Silva T, et al. Quantitative analysis of adipose depots by using chest CT and associations with all-cause mortality in chronic obstructive pulmonary disease: Longitudinal Analysis from MESArthritis Ancillary Study[J]. Radiology, 2021, 299(3): 703-711.
|
| 32 |
Ji Y, Li M, Chang M, et al. Inflammation: Roles in skeletal muscle atrophy[J]. Antioxidants (Basel), 2022, 11(9): 1686.
|
| 33 |
Wang J, Leung KS, Chow SK, et al. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)[J]. J Orthop Translat, 2017, 10: 94-101.
|
| 34 |
Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness[J]. Am J Respir Crit Care Med, 2013, 187(6): 602-608.
|
| 35 |
Hwang HJ, Lee SM, Seo JB, et al. Quantitative vertebral bone density seen on chest CT in chronic obstructive pulmonary disease patients: association with mortality in the korean obstructive lung disease cohort[J]. Korean J Radiol, 2020,21(7):880-890.
|
| 36 |
罗宸婧,盛芳芳,张静,等. 以全球视角对中国慢性阻塞性肺疾病负担及未来趋势分析[J/CD]. 中华肺部疾病杂志(电子版), 2024, 17(6): 855-860.
|